C12N 9/10
Transferases
Official title: Transferases (2.) (ribonucleases C12N9/22)
C12N9/10 (Transferases) appears on 12,525 US grants and 17,469 published applications in this corpus.
Search patents in C12N- Granted patents
- 12,525
- Published applications
- 17,469
- Assignees
- 4,776
- Inventors
- 29,277
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 2 | 0 |
| 1978 | 2 | 0 |
| 1979 | 5 | 0 |
| 1980 | 7 | 0 |
| 1981 | 5 | 0 |
| 1982 | 14 | 0 |
| 1983 | 9 | 0 |
| 1984 | 5 | 0 |
| 1985 | 6 | 0 |
| 1986 | 15 | 0 |
| 1987 | 9 | 0 |
| 1988 | 12 | 0 |
| 1989 | 8 | 0 |
| 1990 | 22 | 0 |
| 1991 | 46 | 0 |
| 1992 | 53 | 0 |
| 1993 | 79 | 0 |
| 1994 | 85 | 0 |
| 1995 | 84 | 0 |
| 1996 | 133 | 0 |
| 1997 | 210 | 0 |
| 1998 | 373 | 0 |
| 1999 | 416 | 0 |
| 2000 | 351 | 0 |
| 2001 | 422 | 77 |
| 2002 | 389 | 598 |
| 2003 | 356 | 1257 |
| 2004 | 338 | 711 |
| 2005 | 272 | 601 |
| 2006 | 331 | 565 |
| 2007 | 428 | 448 |
| 2008 | 350 | 443 |
| 2009 | 286 | 542 |
| 2010 | 337 | 547 |
| 2011 | 319 | 541 |
| 2012 | 334 | 491 |
| 2013 | 333 | 547 |
| 2014 | 415 | 568 |
| 2015 | 452 | 683 |
| 2016 | 453 | 678 |
| 2017 | 484 | 745 |
| 2018 | 498 | 663 |
| 2019 | 532 | 748 |
| 2020 | 515 | 780 |
| 2021 | 540 | 790 |
| 2022 | 471 | 886 |
| 2023 | 404 | 854 |
| 2024 | 470 | 1046 |
| 2025 | 492 | 960 |
| 2026 | 349 | 700 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 9/12Transferring phosphorus containing groups6,039
- C12N 9/1048Glycosyltransferases2,490
- C12N 9/1025Acyltransferases2,158
- C12N 9/1003Transferring one-carbon groups934
- C12N 9/1085Transferring alkyl or aryl groups other than methyl groups927
- C12N 9/1096Transferring nitrogenous groups486
- C12N 9/13Transferring sulfur containing groups268
- C12N 9/1022Transferring aldehyde or ketonic groups260
Recent patents
- Tumor-targeting Salmonella gallinarum strain and use thereof6 Oct 2026US 12,751,978 B2Industry Foundation of Chonnam National University
- Compositions and methods for genetically-encoded high voltage-activated calcium channel blockers using engineered ubiquitin ligases6 Oct 2026US 12,753,228 B2The Trustees of Columbia University in the City of New York
- O-acetyl homoserine-producing microorganism and method for producing o-acetyl homoserine or l-methionine using same6 Oct 2026US 12,753,382 B2Cj Cheiljedang Corporation
- Immortalized keratinocytes, lentivirus for keratinocyte immortalization, and methods of use6 Oct 2026US 12,753,388 B2Regents of the University of Minnesota
- Prime editor system for in vivo genome editing6 Oct 2026US 12,753,397 B2University of Massachusetts
- Method for producing plant-based cheese8 Oct 2026US 2026/0305639 A1Amano Enzyme Inc.
- Methods of treating neurodegenerative disorders8 Oct 2026US 2026/0306669 A1
- Epigenetic repression protein therapy for rasopathies8 Oct 2026US 2026/0306675 A1Battelle Memorial Institute
- Metabolic switches for anti-tumor immunity8 Oct 2026US 2026/0308516 A1Cold Spring Harbor Laboratory
- Chemoenzymatic method for the detection of cell-cell proximity interaction and isolation of tumor-specific antigen reactive t cells for immune therapy8 Oct 2026US 2026/0308537 A1The Scripps Research Institute
Most cited
By later US patents
- Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme2,156US 4,965,188 ACetus Corporation · 1990
- Plant expression constructs1,417US 6,660,911 B2Monsanto Technology LLC · 2003
- Chimeric figwort mosaic virus-elongation factor 1 α promoters and methods of using them1,389US 6,949,696 B2Monsanto Technology LLC · 2005
- Glyphosate resistant plants using hybrid promoter constructs1,380US 7,141,722 B2Monsanto Technology LLC · 2006
- Delivery of exogenous DNA sequences in a mammal1,218US 5,580,859 AVical Incorporated · 1996